Cargando…
Health economic evaluation of gene replacement therapies: methodological issues and recommendations
Objective: To provide recommendations for addressing previously identified key challenges in health economic evaluations of Gene Replacement Therapies (GRTs), including: 1) the assessment of clinical effectiveness; 2) the valuation of health outcomes; 3) the time horizon and extrapolation of effects...
Autores principales: | Aballéa, Samuel, Thokagevistk, Katia, Velikanova, Rimma, Simoens, Steven, Annemans, Lieven, Antonanzas, Fernando, Auquier, Pascal, François, Clément, Fricke, Frank-Ulrich, Malone, Daniel, Millier, Aurélie, Persson, Ulf, Petrou, Stavros, Dabbous, Omar, Postma, Maarten, Toumi, Mondher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Routledge
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7580851/ https://www.ncbi.nlm.nih.gov/pubmed/33144927 http://dx.doi.org/10.1080/20016689.2020.1822666 |
Ejemplares similares
-
Social Preferences for Orphan Drugs: A Discrete Choice Experiment Among the French General Population
por: Toumi, Mondher, et al.
Publicado: (2020) -
Valuation of Treatments for Rare Diseases: A Systematic Literature Review of Societal Preference Studies
por: Dabbous, Omar, et al.
Publicado: (2022) -
Quality of life is predictive of relapse in schizophrenia
por: Boyer, Laurent, et al.
Publicado: (2013) -
Validation of disease states in schizophrenia: comparison of cluster analysis between US and European populations
por: Thokagevistk, Katia, et al.
Publicado: (2016) -
Relapse according to antipsychotic treatment in schizophrenic patients: a propensity-adjusted analysis
por: Millier, Aurelie, et al.
Publicado: (2011)